Depression and Cognitive Phenotype in Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Results of a Comparative Study of a New Scale ESDEPARK Assessing Depressive Symptomatology Specifically in IPDWD vs a General Geriatric Depression Scale.
Objective: To show the Preliminary Results of the ESDEPARK and compare them with a General Geriatric Depression Scale in a sample of patients with IPDWD.…Patient-reported changes from normal in individuals with prodromal and early-motor Parkinson’s disease: a scoping review
Objective: To synthesize published literature about patient-reported symptoms (PRS) or changes from normal in prodromal and early motor stages of Parkinson’s disease (PD) and develop…Depressive Symptomatology and Neuropsychiatric Profile in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.
Objective: : To identify whether depression in patients with IPDWD correlates with different types of behavioral symptoms. Background: Depression is considered a frequent neuropsychiatric pathology…Visuospatial-Visuoconstructive Alterations and Depressive Symptomatology in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.
Objective: To identify whether depressive symptomatology in patients with IPDWD correlates with visuospatial and/or visuoconstructive alterations Background: Visuospatial functioning and/or visuoconstructive skills are a cognitive…Self-perception of Health and Depressive Symptomatology in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.
Objective: To identify whether depressive symptomatology correlates with self-perception of health in patients with IPDWD. Background: Parkinson's disease is a neurodegenerative pathology characterized by motor…Combining MDS-UPDRS Parts 1 and 2: using the patient’s voice
Objective: To test whether the patient-derived MDS-UPDRS Parts assessing non-motor (Part 1) and motor (Part 2) functional impact of PD can be summed to render…Mortality Rate, Cause of Death and Factors Associated with Mortality in Late Stage Parkinson’s Disease
Objective: The aim was to carry out a long-term follow-up of a cohort of patients in late stage Parkinson’s disease (PD) with focus on mortality…Coping strategies in people with Parkinson disease (PwP)
Objective: To compare how PwP coped in two situations along their lives: (a) Parkinson disease diagnosis and (b) COVID-19 pandemic, and how their environment played…Sensor-based digital measurement of gait and wrist pronation-supination in clinically-defined classes of Parkinson’s disease progression identified by unsupervised clustering
Objective: To determine how sensor-based measurement of motor performances relate to the heterogeneity of clinical progression in early Parkinson’s disease (PD). Background: Observed disease progression…Correlation between Motor Sections of UMSARS and MDS-UPDRS
Objective: To determine the correlation between UMSARS II and MDS-UPDRS III. Background: Despite the availability of the Unified Multiple System Atrophy Rating Scale (UMSARS) [1]…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 32
- Next Page »